CureVac raised €300M in a Early VC round in Jun 2020. The company is based in T√ºbingen, Germany. Investors in the round: KfW. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €300M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
